THE SCIENCE
Cognitive decline arises when neurons become hyper-inflammatory and cannot meet energy demands as mitochondrial function weakens. Damaged proteins build up and neurons atrophy, driving memory loss and accelerated aging. By calming inflammation and restoring energy metabolism, targeted interventions help protect brain function and preserve cognition.
Cellular drivers of cognitive decline and aging

Interventions can help
Restore Mitochondrial Function
Neurons require high energy to maintain connections and repair damage. Methylene blue, urolithin A, and AMPK activators enhance mitochondrial efficiency and reduce oxidative stress, improving energy supply and sustaining cognitive performance.



Reduce Neuroinflammation
Chronic inflammation in the brain damages neurons and disrupts signaling. Interventions like LDN and rapamycin calm overactive immune responses and microglial activation, helping to protect brain tissue and slow cognitive decline.
Enhance Autophagy
When protein clearance falters, misfolded and toxic proteins build up in neurons. Rapamycin, metformin, and our autophagy formulations reactivate cellular repair pathways, improving proteostasis and protecting neurons from degeneration.

Reduce Neuroinflammation
Chronic inflammation in the brain damages neurons and disrupts signaling. Interventions like LDN and rapamycin calm overactive immune responses and microglial activation, helping to protect brain tissue and slow cognitive decline.

Restore Mitochondrial Function
Neurons require high energy to maintain connections and repair damage. Methylene blue, urolithin A, and AMPK activators enhance mitochondrial efficiency and reduce oxidative stress, improving energy supply and sustaining cognitive performance.

Enhance Autophagy
When protein clearance falters, misfolded and toxic proteins build up in neurons. Rapamycin, metformin, and our autophagy formulations reactivate cellular repair pathways, improving proteostasis and protecting neurons from degeneration.
Hear from our patients
(Featured In)
(Featured In)
Ahead of the field
“Rapamycin... is at the leading edge of a generation of research trials.”
“I would say that rapamycin is the current best-in-class for a longevity drug”
“Rapamycin... is at the leading edge of a generation of research trials.”
“I would say that rapamycin is the current best-in-class for a longevity drug”
“Rapamycin... is at the leading edge of a generation of research trials.”
“I would say that rapamycin is the current best-in-class for a longevity drug”
“Rapamycin... is at the leading edge of a generation of research trials.”
“I would say that rapamycin is the current best-in-class for a longevity drug”
Reviews
127 reviews
We study the studies
Healthspan longevity experts continuously review the latest clinical research, curating results to help deepen your understanding of aging science.